📊Executive Summary

Researchers have developed a plasma-synthesized copper biosensor that detects the ovarian cancer biomarker CA 125, promising affordable early diagnosis. This new biosensor utilizes a low-temperature plasma synthesis technique, which is environmentally friendly and scalable, potentially revolutionizing point-of-care cancer screening. The technology replaces costly materials like gold and silver with copper, enhancing affordability without sacrificing performance. While further clinical validation is needed, this advancement could lead to broader applications in medical diagnostics, including cardiac and metabolic disorders. The implications for procurement in the medical electronics sector are significant, as this technology could lead to increased demand for copper-based biosensors and related components....